ascopubs.org

Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer.

Report of adverse events of special interest (AESIs) for sintilimab plus a bevacizumab biosimilar (IBI305) in unresectable hepatocellular carcinoma. A multicenter study to investigate the role of ...
The Lancet

Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and ...

eDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea fCancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea ...
220Triathlon

We test the new Giant Revolt Advanced 0 gravel bike for comfort, speed, and versatility for triathlon

In 2013, bike behemoths Giant introduced the purpose-built gravel Revolt range, in the days when gravel as its own category was in its infancy. At the time, many who sought an off-road ride with drop ...
The New York Times

Trump Administration to Pay $1 Billion to Energy Giant to Cancel Wind Farms

In exchange, the French company TotalEnergies would invest in oil and natural gas projects in Texas and elsewhere. By Maxine Joselow and Brad Plumer Maxine Joselow reported from Washington and Brad ...
CNN

Trump administration will pay a French company $1 billion in taxpayer funds to not build wind farms

The Trump administration announced it will pay nearly $1 billion to French energy giant TotalEnergies in exchange for the company abandoning plans to build offshore wind farms in the Atlantic Ocean ...
The Hill

Claim deadline for $1.2B in tax refunds from 2022 nearing, IRS warns

(NEXSTAR) – An estimated $1.2 billion in federal tax refunds remain unclaimed for tax year 2022, and the deadline for taxpayers to collect is fast-approaching, the IRS has warned. The funds are ...